Grifols GRFS
NASDAQ GRFS
$7.31 +0.01 (+0.14%)
At close: Sep 30, 2026 · 4:00 PM EDT

Grifols (GRFS) Notes Payables (2013 - 2015)

Updated

Grifols' Notes Payables was -$73.96 million in the quarter ended Dec 31, 2015, compared with -$68.48 million a year earlier.

Analysis

Grifols (GRFS) Notes Payables (2013 - 2015) Analysis & Trends

As of Dec 31, 2015, Notes Payables at Grifols came in at -$74.95 million.

  • In earlier years, Notes Payables was -$68.48 million in the year ended Dec 31, 2014 and -$61.54 million in the year ended Dec 31, 2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Grifols 4.97 Bn 4.59 Bn 3.33 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2015 -73.96 Mn
Dec 31, 2014 -68.48 Mn
Dec 31, 2013 -61.54 Mn
API Access

Grifols Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=GRFS&period=max&api_key=YOUR_API_KEY